Antibody To Evaluate Prostate Cancer: HJF Signs Distribution Agreement
2/21/2011
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) has signed a licensing agreement with Biocare Medical, a biotechnology company based in Concord, Calif., for the exclusive worldwide sales and distribution rights for the immunohistochemistry of an antibody designed to detect tumor prevalence in prostate cancer patients...
Improving Calcium Supplement With The Help OF Crustaceans
2/21/2011
Ben-Gurion University of the Negev (BGU) researchers have developed a unique technology that stabilizes an otherwise unstable form of calcium carbonate. This mineral form provides significantly higher biological absorption and retention rates than other sources presently used as dietary calcium supplements...
The Charles Rodolphe Brupbacher Prize for Cancer Research 2011 goes to two researchers who have contributed to better understanding of the genetics underlying the growth of tumors. Oncologist Bert Vogelstein has demonstrated how sequential accumulation of mutations leads to colorectal cancer, and Jan H...
Neisseria Meningitidis Disseminates Itself By Sending Out "Scouts"
2/21/2011
Although, in the majority of cases, the localized presence of Neisseria meningitidis in the throat has no consequence, it can sometimes lead to meningitis or septicaemia...
Riverain Medical, an industry leader and innovator in computer-aided detection (CAD) and advanced visualization technologies, announced a poster presentation, "A Superior Chest X-Ray Computer-Aided Detection (CXR CADe) Application: A Reader Study," has been published on the European Society of Radiology's website...
UK Scientists' Discovery Already Saving Patients' Lives
2/20/2011
Patients in the UK with a hereditary immune disorder are benefiting from life-saving treatment, thanks to the work of scientists at Newcastle University. The researchers are among the first in the world to identify the rare syndrome, which devastates the immune system and can lead to hereditary leukaemia and lung disease...
Cyanotech Corporation (Nasdaq Capital Market: CYAN), world leader in microalgae-based health and nutrition supplements, announced that researchers at the University of California at Davis have determined that microalgae-based Hawaiian Spirulina Pacifica® may improve immune function and ameliorate anemia in persons over 50...
Cerus Corporation (NASDAQ:CERS) announced that it has been granted orphan drug status for plasma prepared with the INTERCEPT Blood System for treatment of thrombotic thrombocytopenic purpura (TTP). TTP is a rare, life-threatening blood disorder that typically requires transfusion with large volumes of plasma...
Bellicum Pharmaceuticals, Inc. announced the presentation of Phase I/II safety and efficacy data for BPX-101, a novel drug-activated dendritic cell vaccine for metastatic castrate resistant prostate cancer (mCRPC), in three separate posters at the 2011 Genitourinary Cancers Symposium held in Orlando, Florida on February 17 - 19, 2011...
Between 5 % and 10 % of breast cancer cases are hereditary, arising because the patient inherits from the father or mother a mutation in a gene that is susceptible to causing the illness. BRCA1 and BRCA2 have already been identified as two of the genes to be monitored...